---
title: Effectiveness of Physical Exercise in Women With Fibromyalgia
nct_id: NCT00498264
overall_status: UNKNOWN
phase: PHASE2
sponsor: Federal University of São Paulo
study_type: INTERVENTIONAL
primary_condition: Fibromyalgia
countries: Brazil
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT00498264.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT00498264"
ct_last_update_post_date: 2007-07-10
last_seen_at: "2026-05-12T07:23:24.484Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Effectiveness of Physical Exercise in Women With Fibromyalgia

**Official Title:** Effectiveness of Physical Exercise on Decrease of Pain in Patients With Fibromyalgia:Randomized Clinical Trial

**NCT ID:** [NCT00498264](https://clinicaltrials.gov/study/NCT00498264)

## Key Facts

- **Status:** UNKNOWN
- **Phase:** PHASE2
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 90
- **Lead Sponsor:** Federal University of São Paulo
- **Collaborators:** Universidade Santo Amaro
- **Conditions:** Fibromyalgia
- **Start Date:** 2005-01
- **Completion Date:** 2007-10
- **CT.gov Last Update:** 2007-07-10

## Brief Summary

Fibromyalgia (FMS) is a syndrome expressed by chronic widespread body pain which leads to reduced physical function and frequent use of health care services. Exercise training is commonly recommended as a treatment.

The purpose of this study is to determine whether a supervised resistance muscular exercise (RME) and walking program (WP) are effective in the treatment of FMS on decrease of pain.

The practical of the RME reduces the pain of participants with FMS.

## Detailed Description

This study will evaluate and compare the effectiveness of a supervised resistance muscular exercise (RME) , walking program (WP)and control group (just observation) in women with FMS during 16 weeks, on decrease of pain.

Participants will undergo an assessment including medical some questionnaires to assess their FMS symptoms at baseline, after 8 weeks, 16 weeks and 28 weeks.

## Eligibility

- **Minimum age:** 35 Years
- **Maximum age:** 55 Years
- **Sex:** FEMALE
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Criteria diagnosis according ACR 1990
* Wash-out of medication specific for fibromyalgia for 1 month
* Only paracetamol 750mg will be allowed during the period of study.

Exclusion Criteria:

* Alterations that against indicate the practical one of physical activity evaluated previously in clinical and rheumatology evaluation
```

## Interventions

- **walking program, resistance muscular exercise** (BEHAVIORAL)

## Primary Outcomes

- **Decrease of pain and use of specific medicine for fibromyalgia** _(time frame: 16 weeks)_

## Secondary Outcomes

- **Improvement on phsysical function assessment throughout of 6 minute walk test and specific questionnaire: FIQ (Fibromyalgia Impact questionnarie) and SF-36 (Quality of life)** _(time frame: 16 weeks)_

## Locations (1)

- University of Santo Amaro - Ambulatory of Special Conditions, São Paulo, São Paulo, Brazil — _RECRUITING_

## Recent Field Changes (last 30 days)

- `outcomes.primary` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.university of santo amaro - ambulatory of special conditions|são paulo|são paulo|brazil` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT00498264.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT00498264*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*